David Veesler: Difference between revisions

Edit links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
m v2.04b - Bot T20 CW#61 - Fix errors for CW project (Reference before punctuation)
Reference edited with ProveIt #proveit | Add: pmc, pmid, pages, issue, volume, journal, year, title, authors 1-6. | Use this tool. Report bugs. | #UCB_Gadget
Line 1: Line 1:
'''David Veesler''' is a French biochemist and an assistant professor in the Department of Biochemistry at the [[University of Washington]],<ref>[https://depts.washington.edu/biowww/pages/faculty-Veesler.shtml David Veesler faculty profile, University of Washington]</ref> where his group focuses on the study the structural biology of infectious diseases.<ref>[https://faculty.washington.edu/dveesler/ Veesler Lab website]</ref> His team recently helped determine the structure of the [[SARS-CoV-2]] spike glycoprotein <ref>[https://www.cell.com/cell/pdf/S0092-8674(20)30262-2.pdf Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein, Cell (2020)]</ref> using [[Cryo-EM]] techniques, and it is currently trying to identify neutralizing antibodies for [[SARS-CoV-2]] that could be used as a preventative treatment against [[COVID-19]] or as a post-exposure therapy<ref>[https://www.nature.com/articles/s41586-020-2349-y Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, Nature (2020)]</ref> using [[X-ray crystallography]].<ref>[https://newscenter.lbl.gov/2020/05/19/xray-covid19-antibodies/ X-ray Experiments Zero in on COVID-19 Antibodies – Berkeley Lab News Center]</ref> Veesler is [[Howard Hughes Medical Institute|Howard Hughes Medical Investigators]].<ref>[https://www.hhmi.org/news/hhmi-invests-300-million-33-new-investigators HHMI Invests $300 Million in 33 New Investigators] – HHMI</ref>
'''David Veesler''' is a French biochemist and an assistant professor in the Department of Biochemistry at the [[University of Washington]],<ref>[https://depts.washington.edu/biowww/pages/faculty-Veesler.shtml David Veesler faculty profile, University of Washington]</ref> where his group focuses on the study the structural biology of infectious diseases.<ref>[https://faculty.washington.edu/dveesler/ Veesler Lab website]</ref> His team recently helped determine the structure of the [[SARS-CoV-2]] spike glycoprotein <ref>{{Cite journal |url=https://www.cell.com/cell/pdf/S0092-8674(20)30262-2.pdf |doi=10.1016/j.cell.2020.02.058 |title=Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein |year=2020 |last1=Walls |first1=Alexandra C. |last2=Park |first2=Young-Jun |last3=Tortorici |first3=M. Alejandra |last4=Wall |first4=Abigail |last5=McGuire |first5=Andrew T. |last6=Veesler |first6=David |journal=Cell |volume=181 |issue=2 |pages=281–292.e6 |pmid=32155444 |pmc=7102599 }}</ref> using [[Cryo-EM]] techniques, and it is currently trying to identify neutralizing antibodies for [[SARS-CoV-2]] that could be used as a preventative treatment against [[COVID-19]] or as a post-exposure therapy<ref>[https://www.nature.com/articles/s41586-020-2349-y Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, Nature (2020)]</ref> using [[X-ray crystallography]].<ref>[https://newscenter.lbl.gov/2020/05/19/xray-covid19-antibodies/ X-ray Experiments Zero in on COVID-19 Antibodies – Berkeley Lab News Center]</ref> Veesler is [[Howard Hughes Medical Institute|Howard Hughes Medical Investigators]].<ref>[https://www.hhmi.org/news/hhmi-invests-300-million-33-new-investigators HHMI Invests $300 Million in 33 New Investigators] – HHMI</ref>


== Education ==
== Education ==

Revision as of 07:26, 25 July 2023

David Veesler is a French biochemist and an assistant professor in the Department of Biochemistry at the University of Washington,[1] where his group focuses on the study the structural biology of infectious diseases.[2] His team recently helped determine the structure of the SARS-CoV-2 spike glycoprotein [3] using Cryo-EM techniques, and it is currently trying to identify neutralizing antibodies for SARS-CoV-2 that could be used as a preventative treatment against COVID-19 or as a post-exposure therapy[4] using X-ray crystallography.[5] Veesler is Howard Hughes Medical Investigators.[6]

Education

David Veesler earned his Ph.D. from Aix-Marseille University in France in 2010. He was a visiting researcher at the University of Zurich in Switzerland during his PhD, and joined the Scripps Research Institute in La Jolla, California as postdoctoral fellow from 2011 to 2014 before joining the University of Washington.[7]

Awards and honors

  • 2013 Microscopy Society of America Presidential Scholar Award
  • 2012 The Scripps Research Institute Fall Research Symposium Award
  • 2011 Marie-Curie International Outgoing Postdoctoral Fellowship
  • 2011 French Crystallographic Association PhD award
  • 2009 Wyatt Technology award
  • 2006 French Ministry of Higher Education and Research PhD fellowship

References

  1. ^ David Veesler faculty profile, University of Washington
  2. ^ Veesler Lab website
  3. ^ Walls, Alexandra C.; Park, Young-Jun; Tortorici, M. Alejandra; Wall, Abigail; McGuire, Andrew T.; Veesler, David (2020). "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein" (PDF). Cell. 181 (2): 281–292.e6. doi:10.1016/j.cell.2020.02.058. PMC 7102599. PMID 32155444.
  4. ^ Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, Nature (2020)
  5. ^ X-ray Experiments Zero in on COVID-19 Antibodies – Berkeley Lab News Center
  6. ^ HHMI Invests $300 Million in 33 New Investigators – HHMI
  7. ^ David Veesler – CV, University of Washington
Retrieved from "https://en.wikipedia.org/w/index.php?title=David_Veesler&oldid=1167031593"